Bacterial pneumonia natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
(11 intermediate revisions by 2 users not shown)
Line 1: Line 1:
'''Editor-In-Chief:''' [[User:C Michael Gibson|C. Michael Gibson, M.S., M.D.]] [Mailto:charlesmichaelgibson@gmail.com| <nowiki>[1]</nowiki>]; '''Associate Editor(s)-in-Chief:''' Arooj Naz<br />
'''Editor-In-Chief:''' [[User:C Michael Gibson|C. Michael Gibson, M.S., M.D.]] [Mailto:charlesmichaelgibson@gmail.com| <nowiki>[1]</nowiki>]; '''Associate Editor(s)-in-Chief:''' [[User:AroojNaz|Arooj Naz, M.B.B.S]]<br />
__NOTOC__
__NOTOC__
{{Bacterial pneumonia}}
{{Bacterial pneumonia}}


==Overview==
==Overview==
Bacterial pneumonia is often transmitted via oral secretions. Symptoms may vary amongst individuals but commonly include abrupt fever, chills, rigours, and cough. There are a multitude of complications and these may determine the outcome of recovery.  
[[Bacterial pneumonia]] is often transmitted via oral secretions and undergoes a variety of stages including congestion, hepatization and resolution. Symptoms may vary amongst individuals but commonly include abrupt [[fever]], [[chills]], [[rigors]], and [[cough]]. Infectious organisms are commonly transmitted via oral secretions containing droplets and the incubation period is generally short and ranges from 1-3 days. Germs can also be transferred by touching unclean surfaces with hands that may later come in contact with the [[eyes]], [[nostrils]], or [[mouth]] allowing bacteria to enter the [[body]]. There are a multitude of [[pulmonary]] and extra-pulmonary complications that contribute to determining the outcome of recovery. Common complications include [[acute respiratory distress]], [[pleural effusion]], [[sepsis]] and [[shock]]. Prognosis varies according to age and underlying conditions such as [[bronchiectasis]], [[abscesses]], and [[neoplasms]]. The [[CURB-65]] scale takes into account [[confusion]], [[BUN]], [[respiratory rate]], [[blood pressure]], and [[age]]. A score of 3 or more requires a prolonged hospital duration and has a higher risk of mortality. This criteria has proven to be a useful tool in predicting the outcome of disease.


==Natural History==
==Natural History==
Line 10: Line 10:
===Route of Transmission===  
===Route of Transmission===  


*Contamination is via oral secretions containing droplets; this commonly occurs when coughing or sneezing.<ref name="nhs">{{cite web|url=https://www.nhs.uk/common-health-questions/infections/is-pneumonia-contagious/}} </ref>
*Contamination is via oral secretions containing droplets; this commonly occurs when [[coughing]] or [[sneezing]].<ref name="nhs">{{cite web|url=https://www.nhs.uk/common-health-questions/infections/is-pneumonia-contagious/}} </ref>
*Germs can also be transferred by touching unclean surfaces with hands that may later come in contact with the eyes, nostrils, or mouth allowing bacteria to enter the body.
*Germs can also be transferred by touching unclean surfaces with hands that may later come in contact with the [[eyes]], [[nostrils]], or [[mouth]] allowing [[bacteria]] to enter the body.


===Incubation period===  
===Incubation period===  


*The incubation period is generally short and ranges from 1-3 days.<ref name="cdc">{{cite web|url=http://www.cdc.gov/pneumococcal/clinicians/clinical-features.html| title=CDC Pneumococcal Disease Clinical Features}} </ref> This does not however determine the period an individual may experience symptoms for, which may be prolonged due to the development of complications.
*The [[incubation period]] is generally short and ranges from 1-3 days.<ref name="cdc">{{cite web|url=http://www.cdc.gov/pneumococcal/clinicians/clinical-features.html| title=CDC Pneumococcal Disease Clinical Features}} </ref> This does not however determine the period an individual may experience symptoms for, which may be prolonged due to the development of [[complications]].


===Presenting Symptoms===  
===Presenting Symptoms===  


*Common symptoms:<ref name="cdc" /> abrupt fever, chills, rigors, cough (often productive). If present, the colour of any phlegm may help determine the underlying pathogen but must still be confirmed to treat with the correct antibiotics. Some examples of colour specific sputum include:<ref name="pmid30712048" />
*Common symptoms:<ref name="cdc" /> abrupt [[fever]], [[chills]], [[rigors]], [[cough]] (often [[Productive cough|productive]]). If present, the colour of any [[phlegm]] may help determine the underlying pathogen but must still be confirmed to treat with the correct [[antibiotics]]. Some examples of sputum specifications include:<ref name="pmid30712048" />
**Currant Jelly sputum: ''[[Klebsiella]]''
**Currant Jelly sputum: ''[[Klebsiella]]''
**Rust coloured sputum: ''[[Streptococcus pneumoniae]]''
**Rust coloured sputum: ''[[Streptococcus pneumoniae]]''
**Green sputum: ''[[Haemophilus|Hemophilus]], [[Pseudomonas]]''
**Green sputum: ''[[Haemophilus|Hemophilus]], [[Pseudomonas]]''
**Foul smelling/ bad-tasting sputum: ''[[Anaerobic organism|Anaerobes]]''
**Foul smelling/ bad-tasting sputum: ''[[Anaerobic organism|Anaerobes]]''
*Other symptoms:<ref name="cdc" /> pleuritic chest pain, dyspnea, tachypnea, myalgias, generalized weakness and fatigue.
*Other symptoms:<ref name="cdc" /> [[pleuritic chest pain]], [[dyspnea]], [[tachypnea]], [[myalgias]], [[generalized weakness]] and [[fatigue]]


===Stages===
===Stages===
Line 57: Line 57:
==Prognosis==
==Prognosis==


*There is a relatively good prognosis in patients that are younger with fewer comorbidities and considered generally healthy. As a patients age increases, so does the likelihood of an unfavourable outcome. Antibiotic resistance poses difficulty in adequately treating patients and may affect failure rates.<ref name="pmid30020693">{{cite journal| author=| title=StatPearls | journal= | year= 2021 | volume=  | issue=  | pages=  | pmid=30020693 | doi= | pmc= | url= }} </ref>
*There is a relatively good prognosis in patients that are younger with fewer [[comorbidities]] and considered generally healthy. As a patients age increases, so does the likelihood of an unfavourable outcome. Antibiotic resistance poses difficulty in adequately treating patients and may affect failure rates.<ref name="pmid30020693">{{cite journal| author=| title=StatPearls | journal= | year= 2021 | volume=  | issue=  | pages=  | pmid=30020693 | doi= | pmc= | url= }} </ref>
*The CURB 65 Score<ref name="pmid32474039">{{cite journal| author=Nguyen Y, Corre F, Honsel V, Curac S, Zarrouk V, Fantin B | display-authors=etal| title=Applicability of the CURB-65 pneumonia severity score for outpatient treatment of COVID-19. | journal=J Infect | year= 2020 | volume= 81 | issue= 3 | pages= e96-e98 | pmid=32474039 | doi=10.1016/j.jinf.2020.05.049 | pmc=7255987 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32474039  }} </ref> is used as a standard score to predict mortality rates following pneumonia infections. A score of '''0-1''' is considered ''low risk'' and has a minimal risk of death, '''2''' is generally an intermediate risk requiring a short inpatient hospital stay with an increased risk of 30 - day mortality. A score of '''3 or more''' requires a prolonged hospital duration and has a higher risk of mortality.
*The [[CURB 65|CURB 65 Score]]<ref name="pmid32474039">{{cite journal| author=Nguyen Y, Corre F, Honsel V, Curac S, Zarrouk V, Fantin B | display-authors=etal| title=Applicability of the CURB-65 pneumonia severity score for outpatient treatment of COVID-19. | journal=J Infect | year= 2020 | volume= 81 | issue= 3 | pages= e96-e98 | pmid=32474039 | doi=10.1016/j.jinf.2020.05.049 | pmc=7255987 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32474039  }} </ref> is used as a standard score to predict mortality rates following pneumonia infections. A score of '''0 -1''' is considered ''low risk'' and has a minimal risk of death, '''2''' is generally an intermediate risk requiring a short inpatient hospital stay with an increased risk of 30 - day mortality. A score of '''3 or more''' requires a prolonged hospital duration and has a higher risk of mortality.


Each of the following categories is ''1 point'':
Each of the following categories is ''1 point'':


#Confusion (new onset)
#[[Confusion|'''C'''onfusion]] (new onset)
#Blood urea nitrogen >7 mmol/L
#[[Blood urea nitrogen|Blood '''u'''rea nitrogen]] >7 mmol/L
#Respiratory rate ≥ 30 breaths/ minute
#[[Respiratory rate|'''R'''espiratory rate]] ≥ 30 breaths/ minute
#Systolic blood pressure < 90 mm Hg or Diastolic blood pressure ≤ 60 mm Hg
#[[Systolic blood pressure|Systolic '''b'''lood pressure]] < 90 mm Hg or [[Diastolic blood pressure]] ≤ 60 mm Hg
#Age ≥ 65 years
#[[Age]] ≥ '''65''' years


If patients are non-responsive to [[antibiotics]], a ''non-resolving'' pneumonia may develop after a period of approximately 72 hours<ref name="pmid30115336">{{cite journal| author=Grief SN, Loza JK| title=Guidelines for the Evaluation and Treatment of Pneumonia. | journal=Prim Care | year= 2018 | volume= 45 | issue= 3 | pages= 485-503 | pmid=30115336 | doi=10.1016/j.pop.2018.04.001 | pmc=7112285 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30115336  }} </ref>. In such cases, the mortality increases 5 fold. This subtype of ''non-resolving'' pneumonia may appear in two conditions:
#progressively resolving pneumonia followed by a rapid clinical deterioration ''or''
#persistent pneumonia that has not displayed clinical stability
Some underlying conditions may prove to exacerbate the development of non-resolving pneumonia. These include (''BAD OMEN''):
[[Bronchiolitis obliterans|'''B'''ronchiolitis obliterans]], [[Bronchiectasis|'''B'''ronchiectasis]], [[Influenza B virus|Influenza '''B''']]
'''A'''ge > 60, [[Aspiration|'''A'''spiration]], [[Abscess|'''A'''bscess]], '''A'''typical pathogens eg, [[Legionella]], [[Mycoplasma]], [[Chlamydia pneumonia|Chlamydia]]
'''D'''rug resistant pneumonia
'''O'''pportunistic pathogens
'''M'''isdiagnosis ([[fungal infections]], [[sarcoidosis]], [[TB|Tuberculosis]])
[[Embolism|'''E'''mbolism]], [[Empyema|'''E'''mpyema]]
[[Nosocomial pneumonia|'''N'''osocomial pneumonia]], [[Neoplasm|'''N'''eoplasm]]


==References==
==References==
Line 78: Line 98:
[[Category:Pneumonia|Pneumonia]]
[[Category:Pneumonia|Pneumonia]]
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
[[Category:Up-to-date]]


{{WH}}
{{WH}}
{{WS}}
{{WS}}

Latest revision as of 16:32, 13 May 2022

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Arooj Naz, M.B.B.S

Pneumonia Main Page

Bacterial pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Bacterial pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bacterial pneumonia natural history, complications and prognosis On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bacterial pneumonia natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bacterial pneumonia natural history, complications and prognosis

CDC onBacterial pneumonia natural history, complications and prognosis

Bacterial pneumonia natural history, complications and prognosis in the news

Blogs on Bacterial pneumonia natural history, complications and prognosis

to Hospitals Treating Bacterial pneumonia

Risk calculators and risk factors for Bacterial pneumonia natural history, complications and prognosis

Overview

Bacterial pneumonia is often transmitted via oral secretions and undergoes a variety of stages including congestion, hepatization and resolution. Symptoms may vary amongst individuals but commonly include abrupt fever, chills, rigors, and cough. Infectious organisms are commonly transmitted via oral secretions containing droplets and the incubation period is generally short and ranges from 1-3 days. Germs can also be transferred by touching unclean surfaces with hands that may later come in contact with the eyes, nostrils, or mouth allowing bacteria to enter the body. There are a multitude of pulmonary and extra-pulmonary complications that contribute to determining the outcome of recovery. Common complications include acute respiratory distress, pleural effusion, sepsis and shock. Prognosis varies according to age and underlying conditions such as bronchiectasis, abscesses, and neoplasms. The CURB-65 scale takes into account confusion, BUN, respiratory rate, blood pressure, and age. A score of 3 or more requires a prolonged hospital duration and has a higher risk of mortality. This criteria has proven to be a useful tool in predicting the outcome of disease.

Natural History

Route of Transmission

  • Contamination is via oral secretions containing droplets; this commonly occurs when coughing or sneezing.[1]
  • Germs can also be transferred by touching unclean surfaces with hands that may later come in contact with the eyes, nostrils, or mouth allowing bacteria to enter the body.

Incubation period

  • The incubation period is generally short and ranges from 1-3 days.[2] This does not however determine the period an individual may experience symptoms for, which may be prolonged due to the development of complications.

Presenting Symptoms

Stages

Bacterial Pneumonia progresses through a variety of Stages that include:[4]

  1. Congestion: The first stage stage shows a lobe that consists of many neutrophils, some macrophages and serous exudates in the alveoli. Presents on days 1-2 of the infection.
  2. Red hepatization: During this period, the lung lobe undergoes consolidation and appears firm resembling the appearance of that of the liver. There is an abundance of neutrophils, macrophages as well as serous exudate. Presents on days 3-4 of the infection.
  3. Gray hepatization: The lobe continues to appear liver like but had changed rather than red, no appears slightly gray in colour. Presents on days 5-7 of the infection.
  4. Resolution:The final stage of pneumonia is aided by productive cough and/or increased lymphatic drainage in an attempt to “drain” the bacteria and help the lung lobe resolve. Presents around day 8 of the infection.

Complications

  • Common Complications:[3]
  1. Acute respiratory distress
  2. Pleural effusion (unilateral or bilateral)
  3. Heart Failure due to Pneumonia
  4. Sepsis
  5. Septic shock
  • Other Complications:[4]
  1. Bronchiectasis
  2. Pleurisy
  3. Empyema
  4. Arrhythmias
  5. Acute coronary syndrome
  6. Endocarditis
  7. Encephalitis
  8. Meningitis

Prognosis

  • There is a relatively good prognosis in patients that are younger with fewer comorbidities and considered generally healthy. As a patients age increases, so does the likelihood of an unfavourable outcome. Antibiotic resistance poses difficulty in adequately treating patients and may affect failure rates.[4]
  • The CURB 65 Score[5] is used as a standard score to predict mortality rates following pneumonia infections. A score of 0 -1 is considered low risk and has a minimal risk of death, 2 is generally an intermediate risk requiring a short inpatient hospital stay with an increased risk of 30 - day mortality. A score of 3 or more requires a prolonged hospital duration and has a higher risk of mortality.

Each of the following categories is 1 point:

  1. Confusion (new onset)
  2. Blood urea nitrogen >7 mmol/L
  3. Respiratory rate ≥ 30 breaths/ minute
  4. Systolic blood pressure < 90 mm Hg or Diastolic blood pressure ≤ 60 mm Hg
  5. Age ≥ 65 years

If patients are non-responsive to antibiotics, a non-resolving pneumonia may develop after a period of approximately 72 hours[6]. In such cases, the mortality increases 5 fold. This subtype of non-resolving pneumonia may appear in two conditions:

  1. progressively resolving pneumonia followed by a rapid clinical deterioration or
  2. persistent pneumonia that has not displayed clinical stability

Some underlying conditions may prove to exacerbate the development of non-resolving pneumonia. These include (BAD OMEN):

Bronchiolitis obliterans, Bronchiectasis, Influenza B

Age > 60, Aspiration, Abscess, Atypical pathogens eg, Legionella, Mycoplasma, Chlamydia

Drug resistant pneumonia

Opportunistic pathogens

Misdiagnosis (fungal infections, sarcoidosis, Tuberculosis)

Embolism, Empyema

Nosocomial pneumonia, Neoplasm

References

  1. ↑ https://www.nhs.uk/common-health-questions/infections/is-pneumonia-contagious/. Missing or empty |title= (help)
  2. ↑ 2.0 2.1 2.2 "CDC Pneumococcal Disease Clinical Features".
  3. ↑ 3.0 3.1 Alshahwan SI, Alsowailmi G, Alsahli A, Alotaibi A, Alshaikh M, Almajed M; et al. (2019). "The prevalence of complications of pneumonia among adults admitted to a tertiary care center in Riyadh from 2010-2017". Ann Saudi Med. 39 (1): 29–36. doi:10.5144/0256-4947.2019.29. PMC 6464674. PMID 30712048.
  4. ↑ 4.0 4.1 4.2 "StatPearls". 2021. PMID 30020693.
  5. ↑ Nguyen Y, Corre F, Honsel V, Curac S, Zarrouk V, Fantin B; et al. (2020). "Applicability of the CURB-65 pneumonia severity score for outpatient treatment of COVID-19". J Infect. 81 (3): e96–e98. doi:10.1016/j.jinf.2020.05.049. PMC 7255987 Check |pmc= value (help). PMID 32474039 Check |pmid= value (help).
  6. ↑ Grief SN, Loza JK (2018). "Guidelines for the Evaluation and Treatment of Pneumonia". Prim Care. 45 (3): 485–503. doi:10.1016/j.pop.2018.04.001. PMC 7112285 Check |pmc= value (help). PMID 30115336.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Bacterial_pneumonia_natural_history,_complications_and_prognosis&oldid=1723876"